Cocrystal Pharma, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €42.04K
    Gross profit
    -€18.02K
    SG&A expenses
    €4.26M
    R&D expenses
    €6.66M
    EBITDA
    -€10.73M
    D&A
    €189.62K
    EBIT
    -€10.91M
    Interest expenses
    €31.75K
    EBT
    -€10.78M
    Tax expenses
    €0.00
    Net income
    -€10.78M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€89.77K
    Changes in working capital
    -€607.49K
    Operating cash flow
    -€11.53M
    Capex
    €50.77
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€50.77
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    €0.00
    Net financing cash flow
    €0.00
    Foreign exchange effects
    €0.00
    Net change in cash
    -€11.48M
    Cash at end of period
    €4.15M
    Free cash flow
    -€11.53M

    Balance sheet

    Cash and cash equivalents
    €4.09M
    Cash and short-term investments
    €4.09M
    Total receivables
    €1.41M
    Inventory
    €0.00
    Other current assets
    €306.31K
    Total current assets
    €5.80M
    Property, plant & equipment
    €1.42M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €75.50K
    Total non-current assets
    €1.49M
    Total assets
    €7.30M
    Accounts payable
    €734.45K
    Short-term debt
    €271.99K
    Other current liabilities
    €564.56K
    Total current liabilities
    €1.57M
    Long-term debt
    €1.15M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €1.15M
    Total liabilities
    €2.72M
    Common stock
    €8.58K
    Retained earnings
    -€289.81M
    Other equity
    €0.00
    Total equity
    €4.58M
    Total liabilities and shareholders' equity
    €7.30M

    Company information

    Market capitalization
    €12.93M
    Employees
    11
    Enterprise Value
    €11.50M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -235.5% Much better than peer group: -664.5%
    ROA
    -147.7% Much better than peer group: -359.2%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -89.2%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€979.76K

    Notifications